Greg Schneider

Market Access Strategy

Greg is a healthcare strategy and innovation leader who creates and manages integrated frameworks of policy, payer and advocacy strategies to maximize market access, patient access, product differentiation and reimbursement. He develops and executes complex healthcare programs across the care continuum to optimize reimbursement, improve outcomes, decrease costs and enhance patient, caregiver and provider satisfaction. He has experience working in consulting, biotech & pharmaceutical (Wyeth and Pfizer), medical device advanced imaging and diagnostics (Medtronic and Siemens), IT and post-acute care organizations. He has worked in both large and small organizations.

Greg recently led market access, payer, and reimbursement activities for a pre-clearance startup medical technology company developing a novel treatment for traumatic brain injury. He currently consults for a number of small, start up medical device and biopharma organizations.

He serves on the Rutgers University Big Data Advisory Board, is a graduate of Rensselaer Polytechnic Institute and Penn State, lives outside Philadelphia, PA, and is a Volunteer with AFSUSA assisting Foreign Exchange students.